Pfizer licenses promising covid-19 pill to UN-backed nonprofit
- Manufacturing agreement is second by Medicines Patent Pool aiming to boost supplies of pill to prevent infections from turning severe
Pfizer Inc. is licensing its experimental Covid-19 antiviral to a global health organization in an effort to make the pill more readily available to people in low- and middle-income countries.